Pharmacology and Toxicology
-
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro
This article has 7 authors:Reviewed by ScreenIT
-
Development of a highly sensitive bioanalytical assay for the quantification of favipiravir
This article has 11 authors:Reviewed by ScreenIT
-
Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2
This article has 23 authors:Reviewed by ScreenIT
-
Genetic Variability of the SARS-CoV-2 Pocketome
This article has 6 authors:Reviewed by ScreenIT
-
In vitro efficacy of Artemisia extracts against SARS-CoV-2
This article has 7 authors:Reviewed by ScreenIT
-
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
This article has 5 authors:Reviewed by ScreenIT
-
Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone
This article has 4 authors:Reviewed by ScreenIT
-
Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture
This article has 7 authors:Reviewed by ScreenIT
-
KLF2 is a therapeutic target for COVID-19 induced endothelial dysfunction
This article has 4 authors:Reviewed by ScreenIT
-
Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2
This article has 23 authors:Reviewed by ScreenIT